Kolmar BioTech, Inc.

Research Kolmar BioTech, Inc. (215380.KQ) on Bullrun: market cap KRW 36.09B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker215380.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 36.09B
Financial periodQ2 2026
RevenueKRW 10.98B
Net incomeKRW 3.37B
Gross margin32.6%

Valuation Snapshot

latest market cap is KRW 36.09B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	n/a	n/a	-KRW 889.79M	n/a	n/a	KRW 3.83B	KRW 50.52B	KRW 23.38B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 36.09B	n/a	n/a	n/a

Dividend history

About Kolmar BioTech, Inc.

Kolmar BioTech, Inc. engages in the various research services in South Korea. The company provides LAB CLOUD, a bio-specialized accelerator and research platform; and efficacy evaluation, clinical and histopathology, general and inhalation toxicology, behavioral test, bioanalytical, organoids, ADME, NMR analysis, SPR analysis, IND package, shared lab animal facility, breeding lab, microbial and environmental monitoring, and technical support services.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is Kolmar BioTech, Inc.'s market cap?

Kolmar BioTech, Inc.'s market capitalization is KRW 36.09B.